Atlantic Lithium Limited21 September 2022 21 September 2022 Corporate Update Dual Listing on Australian Securities Exchange (ASX) Atlantic Lithium Limited (AIM: ALL, OTC: ALLIF, "Atlantic Lithium" or the "Company"), the funded African-focussed lithium exploration and development company targeting to deliver Ghana's first lithium mine, is pleased to confirm that the Company has today been admitted to the Official List of the Australian Securities Exchange ("ASX"). The Company's shares will commence trading on ASX under the ticker 'A11' at 12:00PM AEST on Monday, 26 September 2022. The Company's shares will continue to trade on the AIM market ("AIM") of the London Stock Exchange under the ticker 'ALL'.
Hey there...I'm a ALL longterm holder in Britain. I think all the A11 IPO share are presold but we go live on ASX at midday in Sydney on Monday 26th so you can buy/sell then. Todays RNS in London above...Cheers..DYOR and GL
- Forums
- ASX - By Stock
- Atlantic Lithium new on ASX
A11
atlantic lithium limited
Add to My Watchlist
12.5%
!
14.0¢

Atlantic Lithium Limited21 September 2022 21 September 2022...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
14.0¢ |
Change
-0.020(12.5%) |
Mkt cap ! $97.04M |
Open | High | Low | Value | Volume |
15.5¢ | 15.5¢ | 14.0¢ | $3.748K | 25.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10896 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
15.0¢ | 117340 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 10896 | 0.145 |
10 | 96983 | 0.140 |
3 | 12533 | 0.135 |
2 | 150000 | 0.130 |
4 | 82583 | 0.120 |
Price($) | Vol. | No. |
---|---|---|
0.150 | 117340 | 1 |
0.155 | 104329 | 2 |
0.160 | 129997 | 2 |
0.170 | 10000 | 1 |
0.175 | 75000 | 1 |
Last trade - 11.12am 30/06/2025 (20 minute delay) ? |
Featured News
A11 (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online